Roger Gammon

3.1k total citations · 2 hit papers
22 papers, 2.2k citations indexed

About

Roger Gammon is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Internal Medicine. According to data from OpenAlex, Roger Gammon has authored 22 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 13 papers in Pulmonary and Respiratory Medicine and 5 papers in Internal Medicine. Recurrent topics in Roger Gammon's work include Peripheral Artery Disease Management (8 papers), Vascular Procedures and Complications (8 papers) and Coronary Interventions and Diagnostics (6 papers). Roger Gammon is often cited by papers focused on Peripheral Artery Disease Management (8 papers), Vascular Procedures and Complications (8 papers) and Coronary Interventions and Diagnostics (6 papers). Roger Gammon collaborates with scholars based in United States, Austria and Germany. Roger Gammon's co-authors include James Hermiller, Warren Sherman, Nabil Dib, Anthony N. DeMaria, Gary L. Schaer, Steven P. Schulman, Ali E. Denktas, Jay H. Traverse, Joshua M. Hare and Timothy D. Henry and has published in prestigious journals such as New England Journal of Medicine, Circulation and Journal of the American College of Cardiology.

In The Last Decade

Roger Gammon

22 papers receiving 2.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction

2009 989 citations Joshua M. Hare, Jay H. Traverse et al. Journal of the American College of Cardiology profile →
Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease

2015 470 citations Kenneth Rosenfield, Michael R. Jaff et al. New England Journal of Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roger Gammon United States	15	1.6k	803	678	566	377	22	2.2k
Robert M. Schainfeld United States	20	1.3k 0.9×	620 0.8×	207 0.3×	1.2k 2.2×	186 0.5×	57	2.6k
Michael Petzsch Germany	16	1.3k 0.8×	731 0.9×	957 1.4×	732 1.3×	440 1.2×	35	2.4k
Jay G. Shake United States	13	693 0.4×	234 0.3×	540 0.8×	286 0.5×	301 0.8×	29	1.3k
Joshua D. Dowell United States	16	1.5k 1.0×	135 0.2×	983 1.4×	1.0k 1.8×	560 1.5×	48	2.5k
Deborah Vela United States	22	1.1k 0.7×	236 0.3×	592 0.9×	704 1.2×	380 1.0×	68	2.5k
Nicolas Chronos United States	21	1.0k 0.7×	438 0.5×	110 0.2×	482 0.9×	137 0.4×	51	1.8k
Tjörvi E. Perry United States	21	1.2k 0.8×	253 0.3×	394 0.6×	830 1.5×	850 2.3×	53	2.5k
Goro Matsumiya Japan	29	1.9k 1.2×	583 0.7×	246 0.4×	442 0.8×	475 1.3×	239	3.2k
Tain-Hsiung Chen Taiwan	25	2.2k 1.4×	210 0.3×	872 1.3×	463 0.8×	184 0.5×	64	3.0k
Éric Abergel France	20	950 0.6×	178 0.2×	476 0.7×	500 0.9×	356 0.9×	47	2.0k

Countries citing papers authored by Roger Gammon

Since Specialization

Citations

This map shows the geographic impact of Roger Gammon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roger Gammon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roger Gammon more than expected).

Fields of papers citing papers by Roger Gammon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roger Gammon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roger Gammon. The network helps show where Roger Gammon may publish in the future.

Co-authorship network of co-authors of Roger Gammon

This figure shows the co-authorship network connecting the top 25 collaborators of Roger Gammon. A scholar is included among the top collaborators of Roger Gammon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roger Gammon. Roger Gammon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brodmann, Marianne, et al.. (2019). Safety and Feasibility of Intravascular Lithotripsy for Treatment of Common Femoral Artery Stenoses. Journal of Endovascular Therapy. 26(3). 283–287. 35 indexed citations

Stuckey, Thomas, Roger Gammon, Jeremiah P. Depta, et al.. (2018). Cardiac Phase Space Tomography: A novel method of assessing coronary artery disease utilizing machine learning. PLoS ONE. 13(8). e0198603–e0198603. 28 indexed citations

Wong, S. Chiu, Roger Gammon, William Bachinsky, et al.. (2017). The CLOSER trial: a multi‐center study on the clinical safety and effectiveness of Closer^TM VSS, a novel resorbable transfemoral vascular access sealing system. Catheterization and Cardiovascular Interventions. 90(5). 798–805. 1 indexed citations

Rosenfield, Kenneth, Michael R. Jaff, Christopher J. White, et al.. (2015). Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery Disease. New England Journal of Medicine. 373(2). 145–153. 470 indexed citations breakdown →

Hermiller, James, Wayne Leimbach, Roger Gammon, et al.. (2015). A prospective, randomized, pivotal trial of a novel extravascular collagen-based closure device compared to manual compression in diagnostic and interventional patients.. PubMed. 27(3). 129–36. 20 indexed citations

Goswami, Nilesh, et al.. (2015). Comparison of the boomerang wire vascular access management system versus manual compression alone during percutaneous diagnostic and interventional cardiovascular procedures: The boomerang™ wire vascular access management trial II. Catheterization and Cardiovascular Interventions. 87(1). 75–81. 2 indexed citations

Rao, Sunil V., Chiara Melloni, Samuel Broderick, et al.. (2010). Evaluation of a New Heparin Agent in Percutaneous Coronary Intervention. Circulation. 121(15). 1713–1721. 19 indexed citations

Hare, Joshua M., Jay H. Traverse, Timothy D. Henry, et al.. (2009). A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalation Study of Intravenous Adult Human Mesenchymal Stem Cells (Prochymal) After Acute Myocardial Infarction. Journal of the American College of Cardiology. 54(24). 2277–2286. 989 indexed citations breakdown →

Krucoff, Mitchell W., Dean J. Kereiakes, John L. Petersen, et al.. (2008). A Novel Bioresorbable Polymer Paclitaxel-Eluting Stent for the Treatment of Single and Multivessel Coronary Disease. Journal of the American College of Cardiology. 51(16). 1543–1552. 80 indexed citations

10.

Ramaiah, Venkatesh G., Roger Gammon, Stefan Kiesz, et al.. (2006). Midterm Outcomes From the TALON Registry:Treating Peripherals With SilverHawk:Outcomes Collection. Journal of Endovascular Therapy. 13(5). 592–602. 89 indexed citations

11.

Kandzari, David E., R. Stefan Kiesz, David E. Allie, et al.. (2006). Procedural and Clinical Outcomes With Catheter-Based Plaque Excision in Critical Limb Ischemia. Journal of Endovascular Therapy. 13(1). 12–22. 61 indexed citations

12.

Heuser, Richard R., Tony Das, Steven B. Laster, et al.. (2004). Usefulness of optical coherent reflectometry with guided radiofrequency energy to treat chronic total occlusions in peripheral arteries (the GRIP trial). The American Journal of Cardiology. 94(8). 1081–1084. 9 indexed citations

13.

Greenberg, Charles S., Jean‐François Tanguay, Roger Gammon, et al.. (1996). Thrombin and fibrin activity in patients treated with enoxaparin, ticlopidine and aspirin versus the conventional coumadin regimen after elective stenting: The ENTICES trial. Journal of the American College of Cardiology. 27(2). 334–334. 3 indexed citations

14.

Muhlestein, Joseph B., Harry R. Phillips, P. J. Quigley, et al.. (1992). Early and late outcome following deployment of a new flexible tantalum intracoronary stent in dogs. American Heart Journal. 124(4). 1058–1067. 8 indexed citations

15.

Chapman, Gregory D., et al.. (1991). In vivo cardiovascular gene transfer via interventional technique: Initial experimental results. Journal of the American College of Cardiology. 17(2). A25–A25. 1 indexed citations

16.

Lim, Chaeseong, Gregory D. Chapman, Roger Gammon, et al.. (1991). Direct in vivo gene transfer into the coronary and peripheral vasculatures of the intact dog.. Circulation. 83(6). 2007–2011. 120 indexed citations

17.

Gammon, Roger, et al.. (1991). Mechanical features of the duke biodegradable intravascular stent. Journal of the American College of Cardiology. 17(2). A235–A235. 28 indexed citations

18.

Chapman, Gregory D., Roger Gammon, Robert P. Bauman, & Richard S. Stack. (1991). Intravascular stents. Trends in Cardiovascular Medicine. 1(3). 127–131. 2 indexed citations

19.

McBride, Wade, John D. Jackman, Roger Gammon, & James T. Willerson. (1988). High-Output Cardiac Failure in Patients with Multiple Myeloma. New England Journal of Medicine. 319(25). 1651–1653. 30 indexed citations

20.

Reisz, George & Roger Gammon. (1986). Toxic Pneumonitis from Mixing Household Cleaners. CHEST Journal. 89(1). 49–52. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact